Astra Merck Prilosec approved for short-term gastric ulcer treatment.
ASTRA MERCK PRILOSEC FOR SHORT-TERM GASTRIC TREATMENT APPROVED, the company announced March 25. The proton-pump inhibitor omeprazole now is indicated "for short-term treatment (4-8 weeks) of active benign gastric ulcer," labeling states. The drug previously was indicated for short-term treatment of duodenal ulcer, erosive esophagitis and poorly responsive GERD, and maintenance therapy for erosive esophagitis and pathological hypersecretory conditions. The supplemental NDA was submitted in late 1994.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth